{"title":"Silk Fibroin and Its Nanocomposites for Wound Care: A Comprehensive Review","authors":"Sushma Indrakumar, Tapan Kumar Dash, Vivek Mishra, Bharat Tandon and Kaushik Chatterjee*, ","doi":"10.1021/acspolymersau.3c00050","DOIUrl":null,"url":null,"abstract":"<p >For most individuals, wound healing is a highly organized, straightforward process, wherein the body transitions through different phases in a timely manner. However, there are instances where external intervention becomes necessary to support and facilitate different phases of the body’s innate healing mechanism. Furthermore, in developing countries, the cost of the intervention significantly impacts access to treatment options as affordability becomes a determining factor. This is particularly true in cases of long-term wound treatment and management, such as chronic wounds and infections. Silk fibroin (SF) and its nanocomposites have emerged as promising biomaterials with potent wound-healing activity. Driven by this motivation, this Review presents a critical overview of the recent advancements in different aspects of wound care using SF and SF-based nanocomposites. In this context, we explore various formats of hemostats and assess their suitability for different bleeding situations. The subsequent sections discuss the primary causes of nonhealing wounds, i.e., prolonged inflammation and infections. Herein, different treatment strategies to achieve immunomodulatory and antibacterial properties in a wound dressing were reviewed. Despite exhibiting excellent pro-healing properties, few silk-based products reach the market. This Review concludes by highlighting the bottlenecks in translating silk-based products into the market and the prospects for the future.</p>","PeriodicalId":72049,"journal":{"name":"ACS polymers Au","volume":"4 3","pages":"168–188"},"PeriodicalIF":4.7000,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acspolymersau.3c00050","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS polymers Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acspolymersau.3c00050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"POLYMER SCIENCE","Score":null,"Total":0}
引用次数: 0
Abstract
For most individuals, wound healing is a highly organized, straightforward process, wherein the body transitions through different phases in a timely manner. However, there are instances where external intervention becomes necessary to support and facilitate different phases of the body’s innate healing mechanism. Furthermore, in developing countries, the cost of the intervention significantly impacts access to treatment options as affordability becomes a determining factor. This is particularly true in cases of long-term wound treatment and management, such as chronic wounds and infections. Silk fibroin (SF) and its nanocomposites have emerged as promising biomaterials with potent wound-healing activity. Driven by this motivation, this Review presents a critical overview of the recent advancements in different aspects of wound care using SF and SF-based nanocomposites. In this context, we explore various formats of hemostats and assess their suitability for different bleeding situations. The subsequent sections discuss the primary causes of nonhealing wounds, i.e., prolonged inflammation and infections. Herein, different treatment strategies to achieve immunomodulatory and antibacterial properties in a wound dressing were reviewed. Despite exhibiting excellent pro-healing properties, few silk-based products reach the market. This Review concludes by highlighting the bottlenecks in translating silk-based products into the market and the prospects for the future.
对大多数人来说,伤口愈合是一个高度有序、简单明了的过程,身体会及时经历不同的阶段。然而,在某些情况下,有必要进行外部干预,以支持和促进人体内在愈合机制的不同阶段。此外,在发展中国家,干预的费用会严重影响治疗方案的获得,因为负担能力成为一个决定性因素。这一点在慢性伤口和感染等长期伤口治疗和管理中尤为明显。蚕丝纤维素(SF)及其纳米复合材料已成为具有强大伤口愈合活性、前景广阔的生物材料。在这一动机的驱动下,本综述对使用 SF 和 SF 基纳米复合材料进行伤口护理的不同方面的最新进展进行了批判性概述。在此背景下,我们探讨了各种形式的止血剂,并评估了它们在不同出血情况下的适用性。随后的章节将讨论伤口不愈合的主要原因,即长期炎症和感染。在此,我们回顾了在伤口敷料中实现免疫调节和抗菌特性的不同治疗策略。尽管蚕丝敷料具有极佳的促进伤口愈合特性,但进入市场的蚕丝产品却寥寥无几。本综述最后强调了丝基产品进入市场的瓶颈和未来前景。